Craft

Lucira Health

Revenue

$93.1 M

FY, 2021

Lucira Health Summary

Company Summary

Overview
Lucira Health (formerly known as Diassess) is a company that develops infectious disease tests. It offers single-use COVID-19 and influenza A and B molecular tests. The company also provides a web-based digital platform allowing patients to submit their test results and track their data.
Type
Subsidiary
Status
Active
Founded
2013
HQ
Emeryville, CA, US | view all locations
Website
https://www.lucirabypfizer.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Richard Narido

    Richard Narido, Chief Financial Officer

  • Nadine Greiner

    Nadine Greiner, Chief Human Resources Officer

  • Debkishore Mitra

    Debkishore Mitra, Co-Founder and Advisor

  • Ivan Dimov

Operating MetricsView all

Patents (US)

4

FY, 2020

Patent Applications (US)

7

FY, 2020

Patents (Foreign)

2

FY, 2020

LocationsView all

1 location detected

  • Emeryville, CA HQ

    United States

    1412 62nd Street

Lucira Health Financials

Summary Financials

Revenue (Q3, 2022)
$34.4M
Gross profit (Q3, 2022)
($99.6M)
Net income (Q3, 2022)
($126.9M)
Cash (Q3, 2022)
$39.8M
EBIT (Q3, 2022)
($126.3M)

Footer menu